Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1CNS 1

Conditions

Hodgkin Disease 37Lymphoma 27Urinary Bladder Neoplasms 9Melanoma 7Carcinoma, Non-Small-Cell Lung 4Urethral Neoplasms 3Prostatic Neoplasms 3Lung Neoplasms 3Skin Neoplasms 2Oligodendroglioma 2Neurofibromatosis 1 2Neoplasms 2Lymphoma, Large-Cell, Anaplastic 2Leukemia 2HIV Infections 2Glioma 2Central Nervous System Neoplasms 2Brain Neoplasms 2Astrocytoma 2Uterine Cervical Neoplasms 1Urothelial Carcinoma of the Bladder 1Testicular Neoplasms 1Testicular Germ Cell Tumor 1Survival Without Progression 1Sarcoma 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Optic Nerve Glioma 1Neurofibroma, Plexiform 1

Interventions

pirfenidone 3trametinib 1tipifarnib 1peginterferon alfa-2b 1nilotinib 1dabrafenib 1cabozantinib 1binimetinib 1Vinblastine 1Surveys and Questionnaires 1Sorafenib 1Pharmacokinetics 1Methotrexate 1Acceptance and Commitment Therapy 1AZD 6244 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neurofibroma, Plexiform × Vinblastine × Clear all
NCT00030264 2018-08-08

Combination Chemotherapy in Treating Patients With Neurofibromatosis and Progressive Plexiform Neurofibromas

Children's Hospital of Philadelphia

Phase 2 Completed
23 enrolled 9 charts
CNSOther neoplasm

Neurofibromatosis 1, Precancerous Conditions, Neurofibroma, Plexiform

Data powered by HemOnc (CC BY 4.0) Colophon âš¡